BioPharmGuy logo
Sponsored By:
Sponsorship Available
Purchase the BioPharmGuy data
Sinclair Research
TyrNovo is defunct.

Fate: Bought by Kitov Therapeutics, Jan 2017, $2M + $1.8M stock


------------------
If you believe any of this information is incorrect, please let us know.